Laxative

Product NDC
63868-549
11-digit product format
638680549
Labeler code
63868
Product ID
63868-549_466a9fb1-5eed-477b-a417-2ca59d2b58f8
Type
HUMAN OTC DRUG
Nonproprietary name
Sennosides
Dosage form
TABLET
Route
ORAL
Labeler
QUALITY CHOICE (Chain Drug Marketing Association)
Application
part334
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2010-03-31
Marketing end
2020-12-31
Substance
SENNOSIDES
Active strength
25 mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct63868-549DDiscontinued by firm2026-10-15
excluded packagepackage63868-54963868-549-24DDiscontinued by firm2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage63868-549-24d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage63868-549-24f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage63868-549-242ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage63868-549-24a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage63868-549-24cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage63868-549-24cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage63868-549-24302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage63868-549-24ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage63868-549-240efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage63868-549-24ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage63868-549-24367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage63868-549-24557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63868-549-24EA - Each63868-549834cafc6-e2dc-40f9-949f-2992169f501f12014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SENNOSIDESACTIVE INGREDIENT3FYP5M0IJXLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
SENNOSIDESACTIVE MOIETY3FYP5M0IJXLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
ACACIAINACTIVE INGREDIENT5C5403N26OLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
AMMONIAINACTIVE INGREDIENT5138Q19F1XLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
ANHYDROUS LACTOSEINACTIVE INGREDIENT3SY5LH9PMKLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENTL11K75P92JLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEINACTIVE INGREDIENTO7TSZ97GEPLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
CALCIUM SULFATE ANHYDROUSINACTIVE INGREDIENTE934B3V59HLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61ULAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
ISOPROPYL ALCOHOLINACTIVE INGREDIENTND2M416302LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
KAOLININACTIVE INGREDIENT24H4NWX5COLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ALAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
POVIDONESINACTIVE INGREDIENTFZ989GH94ELAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
SHELLACINACTIVE INGREDIENT46N107B71OLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
SUCROSEINACTIVE INGREDIENTC151H8M554LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
TALCINACTIVE INGREDIENT7SEV7J4R1ULAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
TARTARIC ACIDINACTIVE INGREDIENTW4888I119HLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2
WHITE WAXINACTIVE INGREDIENT7G1J5DA97FLAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)]2